Pharmacokinetic profile of topiramate in comparison with other new antiepileptic drugs

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Antiepileptic drugs (AEDs) in broad use today have a number of pharmacokinetic liabilities, including a propensity for clinically meaningful drug interactions. Therefore, new AEDs with improved pharmacokinetic characteristics would be welcomed. The pharmacokinetic profiles of six newer AEDs-topiramate (TPM), gabapentin (GBP), vigabatrin (VGB), lamotrigine (LTG), oxcarbazepine (OCBZ), and felbamate-were reviewed. Some of these AEDs offer an improvement in one or more pharmacokinetic parameters compared with traditional AEDs, with TPM, GBP, VGB, and OCBZ demonstrating the most advantageous overall pharmacokinetic profiles.

Original languageEnglish
JournalEpilepsia
Volume37
Issue numberSUPPL. 2
Publication statusPublished - 1996

Fingerprint

Anticonvulsants
Pharmacokinetics
Vigabatrin
felbamate
Drug Interactions
topiramate
gabapentin
oxcarbazepine

Keywords

  • Ad verse events
  • Anticonvulsants
  • Epilepsy
  • Interactions
  • Pharmacokinetics
  • Seizures
  • Topiramate

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

Pharmacokinetic profile of topiramate in comparison with other new antiepileptic drugs. / Perucca, Emilio.

In: Epilepsia, Vol. 37, No. SUPPL. 2, 1996.

Research output: Contribution to journalArticle

@article{d38d73d189fc4edfa65b56e0d7810668,
title = "Pharmacokinetic profile of topiramate in comparison with other new antiepileptic drugs",
abstract = "Antiepileptic drugs (AEDs) in broad use today have a number of pharmacokinetic liabilities, including a propensity for clinically meaningful drug interactions. Therefore, new AEDs with improved pharmacokinetic characteristics would be welcomed. The pharmacokinetic profiles of six newer AEDs-topiramate (TPM), gabapentin (GBP), vigabatrin (VGB), lamotrigine (LTG), oxcarbazepine (OCBZ), and felbamate-were reviewed. Some of these AEDs offer an improvement in one or more pharmacokinetic parameters compared with traditional AEDs, with TPM, GBP, VGB, and OCBZ demonstrating the most advantageous overall pharmacokinetic profiles.",
keywords = "Ad verse events, Anticonvulsants, Epilepsy, Interactions, Pharmacokinetics, Seizures, Topiramate",
author = "Emilio Perucca",
year = "1996",
language = "English",
volume = "37",
journal = "Epilepsia",
issn = "0013-9580",
publisher = "Blackwell Publishing Inc.",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Pharmacokinetic profile of topiramate in comparison with other new antiepileptic drugs

AU - Perucca, Emilio

PY - 1996

Y1 - 1996

N2 - Antiepileptic drugs (AEDs) in broad use today have a number of pharmacokinetic liabilities, including a propensity for clinically meaningful drug interactions. Therefore, new AEDs with improved pharmacokinetic characteristics would be welcomed. The pharmacokinetic profiles of six newer AEDs-topiramate (TPM), gabapentin (GBP), vigabatrin (VGB), lamotrigine (LTG), oxcarbazepine (OCBZ), and felbamate-were reviewed. Some of these AEDs offer an improvement in one or more pharmacokinetic parameters compared with traditional AEDs, with TPM, GBP, VGB, and OCBZ demonstrating the most advantageous overall pharmacokinetic profiles.

AB - Antiepileptic drugs (AEDs) in broad use today have a number of pharmacokinetic liabilities, including a propensity for clinically meaningful drug interactions. Therefore, new AEDs with improved pharmacokinetic characteristics would be welcomed. The pharmacokinetic profiles of six newer AEDs-topiramate (TPM), gabapentin (GBP), vigabatrin (VGB), lamotrigine (LTG), oxcarbazepine (OCBZ), and felbamate-were reviewed. Some of these AEDs offer an improvement in one or more pharmacokinetic parameters compared with traditional AEDs, with TPM, GBP, VGB, and OCBZ demonstrating the most advantageous overall pharmacokinetic profiles.

KW - Ad verse events

KW - Anticonvulsants

KW - Epilepsy

KW - Interactions

KW - Pharmacokinetics

KW - Seizures

KW - Topiramate

UR - http://www.scopus.com/inward/record.url?scp=0029897629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029897629&partnerID=8YFLogxK

M3 - Article

C2 - 8641245

AN - SCOPUS:0029897629

VL - 37

JO - Epilepsia

JF - Epilepsia

SN - 0013-9580

IS - SUPPL. 2

ER -